Drugs / CNTX-4975-05
CNTX-4975-05
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03576508 | Jun → Sep 2018 | osteoarthritis, knee | Centrexion Therapeutics | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT03661996 | Sep 2018 → Oct 2019 | osteoarthritis, knee | Centrexion Therapeutics | Completed | No outcome recorded |
| Phase 3 | NCT03660943 | Sep 2018 → Jun 2020 | osteoarthritis, knee | Centrexion Therapeutics | Completed | No outcome recorded |
| Phase 3 | NCT03429049 | Jan 2018 → Nov 2019 | osteoarthritis, knee | Centrexion Therapeutics | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03472677 Background | Mar → Jul 2018 | osteoarthritis, knee | Centrexion Therapeutics | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CNTX-4975-05 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03576508 ↗ |
| Known as | capsaicin | “CNTX-4975-05 (capsaicin)” NCT03429049 ↗ |
| Known as | trans-capsaicin | “CNTX-4975-05 (trans-capsaicin)” NCT03472677 ↗ |
| Route | Other | “intra-articular injection” NCT03429049 ↗ |